nodes	percent_of_prediction	percent_of_DWPC	metapath
Pranlukast—CYP2C9—Acetylsalicylic acid—Kawasaki disease	0.113	1	CbGbCtD
Pranlukast—IL5—Inflammatory Response Pathway—CD40—Kawasaki disease	0.0702	0.0791	CbGpPWpGaD
Pranlukast—IL5—Cytokines and Inflammatory Response—IL10—Kawasaki disease	0.0585	0.066	CbGpPWpGaD
Pranlukast—IL5—Cytokines and Inflammatory Response—CD4—Kawasaki disease	0.0332	0.0375	CbGpPWpGaD
Pranlukast—IL5—Allograft Rejection—CD40—Kawasaki disease	0.0324	0.0365	CbGpPWpGaD
Pranlukast—IL5—IL4-mediated signaling events—IL10—Kawasaki disease	0.0301	0.0339	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—ITPKC—Kawasaki disease	0.0293	0.033	CbGpPWpGaD
Pranlukast—IL5—AP-1 transcription factor network—IL10—Kawasaki disease	0.0273	0.0308	CbGpPWpGaD
Pranlukast—IL5—Allograft Rejection—IL10—Kawasaki disease	0.0248	0.0279	CbGpPWpGaD
Pranlukast—NFKB1—CD40/CD40L signaling—CD40—Kawasaki disease	0.0247	0.0278	CbGpPWpGaD
Pranlukast—IL5—Regulation of nuclear SMAD2/3 signaling—IL10—Kawasaki disease	0.0243	0.0274	CbGpPWpGaD
Pranlukast—NFKB1—Osteopontin Signaling—MMP9—Kawasaki disease	0.0211	0.0238	CbGpPWpGaD
Pranlukast—TNF—Overview of nanoparticle effects—CRP—Kawasaki disease	0.0202	0.0227	CbGpPWpGaD
Pranlukast—TNF—Cytokines and Inflammatory Response—IL10—Kawasaki disease	0.0181	0.0204	CbGpPWpGaD
Pranlukast—NFKB1—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—Kawasaki disease	0.0161	0.0181	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis Modulation and Signaling—BLK—Kawasaki disease	0.0141	0.0159	CbGpPWpGaD
Pranlukast—IL5—AP-1 transcription factor network—MMP9—Kawasaki disease	0.0135	0.0152	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Receptor Signaling Pathway—BLK—Kawasaki disease	0.0134	0.0151	CbGpPWpGaD
Pranlukast—NFKB1—IL1 and megakaryotyces in obesity—MMP9—Kawasaki disease	0.0129	0.0146	CbGpPWpGaD
Pranlukast—NFKB1—Vitamin B12 Metabolism—CRP—Kawasaki disease	0.012	0.0136	CbGpPWpGaD
Pranlukast—NFKB1—IL12-mediated signaling events—CCR5—Kawasaki disease	0.0114	0.0128	CbGpPWpGaD
Pranlukast—IL5—Allograft Rejection—VEGFA—Kawasaki disease	0.011	0.0124	CbGpPWpGaD
Pranlukast—NFKB1—Toll-like Receptor Signaling Pathway—CD40—Kawasaki disease	0.0107	0.0121	CbGpPWpGaD
Pranlukast—NFKB1—Osteopontin-mediated events—MMP9—Kawasaki disease	0.0105	0.0119	CbGpPWpGaD
Pranlukast—NFKB1—IL23-mediated signaling events—CD4—Kawasaki disease	0.0105	0.0118	CbGpPWpGaD
Pranlukast—TNF—Cytokines and Inflammatory Response—CD4—Kawasaki disease	0.0103	0.0116	CbGpPWpGaD
Pranlukast—NFKB1—amb2 Integrin signaling—MMP9—Kawasaki disease	0.0103	0.0116	CbGpPWpGaD
Pranlukast—TNF—Allograft Rejection—CD40—Kawasaki disease	0.01	0.0113	CbGpPWpGaD
Pranlukast—NFKB1—Folate Metabolism—CRP—Kawasaki disease	0.00978	0.011	CbGpPWpGaD
Pranlukast—NFKB1—Downstream TCR signaling—CD4—Kawasaki disease	0.00967	0.0109	CbGpPWpGaD
Pranlukast—TNF—Vitamin B12 Metabolism—CRP—Kawasaki disease	0.00916	0.0103	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—FCGR2A—Kawasaki disease	0.00902	0.0102	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of toll-like receptor signaling pathway—CD40—Kawasaki disease	0.00837	0.00943	CbGpPWpGaD
Pranlukast—NFKB1—TWEAK Signaling Pathway—MMP9—Kawasaki disease	0.00826	0.00931	CbGpPWpGaD
Pranlukast—TNF—Matrix Metalloproteinases—MMP9—Kawasaki disease	0.00824	0.00928	CbGpPWpGaD
Pranlukast—NFKB1—TCR Signaling Pathway—CCR5—Kawasaki disease	0.00821	0.00925	CbGpPWpGaD
Pranlukast—TNF—Toll-like Receptor Signaling Pathway—CD40—Kawasaki disease	0.00817	0.0092	CbGpPWpGaD
Pranlukast—TNF—IL23-mediated signaling events—CD4—Kawasaki disease	0.008	0.00902	CbGpPWpGaD
Pranlukast—TNF—amb2 Integrin signaling—MMP9—Kawasaki disease	0.00782	0.00882	CbGpPWpGaD
Pranlukast—NFKB1—Selenium Micronutrient Network—CRP—Kawasaki disease	0.00777	0.00876	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—BLK—Kawasaki disease	0.00768	0.00865	CbGpPWpGaD
Pranlukast—TNF—Allograft Rejection—IL10—Kawasaki disease	0.00768	0.00865	CbGpPWpGaD
Pranlukast—TNF—Folate Metabolism—CRP—Kawasaki disease	0.00745	0.0084	CbGpPWpGaD
Pranlukast—NFKB1—TCR signaling—CD4—Kawasaki disease	0.00723	0.00815	CbGpPWpGaD
Pranlukast—NFKB1—IL12-mediated signaling events—CD4—Kawasaki disease	0.00713	0.00804	CbGpPWpGaD
Pranlukast—NFKB1—Aryl Hydrocarbon Receptor—VEGFA—Kawasaki disease	0.0069	0.00777	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—CD40—Kawasaki disease	0.00637	0.00718	CbGpPWpGaD
Pranlukast—TNF—TWEAK Signaling Pathway—MMP9—Kawasaki disease	0.00629	0.00709	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—CCR5—Kawasaki disease	0.00624	0.00704	CbGpPWpGaD
Pranlukast—TNF—Selenium Micronutrient Network—CRP—Kawasaki disease	0.00592	0.00667	CbGpPWpGaD
Pranlukast—NFKB1—LPA receptor mediated events—MMP9—Kawasaki disease	0.0059	0.00665	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—IL10—Kawasaki disease	0.00585	0.00659	CbGpPWpGaD
Pranlukast—NFKB1—AGE/RAGE pathway—MMP9—Kawasaki disease	0.00575	0.00649	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CCR5—Kawasaki disease	0.00535	0.00603	CbGpPWpGaD
Pranlukast—TNF—Aryl Hydrocarbon Receptor—VEGFA—Kawasaki disease	0.00526	0.00592	CbGpPWpGaD
Pranlukast—NFKB1—Oncostatin M Signaling Pathway—VEGFA—Kawasaki disease	0.00523	0.0059	CbGpPWpGaD
Pranlukast—NFKB1—TCR Signaling Pathway—CD4—Kawasaki disease	0.00516	0.00581	CbGpPWpGaD
Pranlukast—IL5—Platelet activation, signaling and aggregation—VEGFA—Kawasaki disease	0.00484	0.00545	CbGpPWpGaD
Pranlukast—IL5—Immune System—FCGR2A—Kawasaki disease	0.00476	0.00537	CbGpPWpGaD
Pranlukast—IL5—Immune System—BLK—Kawasaki disease	0.00462	0.00521	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—IL10—Kawasaki disease	0.00445	0.00502	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—CCR5—Kawasaki disease	0.00407	0.00459	CbGpPWpGaD
Pranlukast—IL5—Immune System—CD40—Kawasaki disease	0.00384	0.00433	CbGpPWpGaD
Pranlukast—TNF—Allograft Rejection—VEGFA—Kawasaki disease	0.00341	0.00384	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—FCGR2A—Kawasaki disease	0.00332	0.00375	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—CCR5—Kawasaki disease	0.00321	0.00362	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—BLK—Kawasaki disease	0.0031	0.00349	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—CCR5—Kawasaki disease	0.00291	0.00328	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—MMP9—Kawasaki disease	0.00275	0.0031	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—VEGFA—Kawasaki disease	0.00267	0.003	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—VEGFA—Kawasaki disease	0.0026	0.00293	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—CD40—Kawasaki disease	0.00257	0.0029	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—VEGFA—Kawasaki disease	0.00249	0.00281	CbGpPWpGaD
Pranlukast—IL5—Immune System—CRP—Kawasaki disease	0.00247	0.00279	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—CCR5—Kawasaki disease	0.0023	0.00259	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—VEGFA—Kawasaki disease	0.00221	0.00249	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—CCR5—Kawasaki disease	0.00209	0.00236	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—VEGFA—Kawasaki disease	0.00198	0.00223	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—FCGR2A—Kawasaki disease	0.00194	0.00218	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—BLK—Kawasaki disease	0.00188	0.00212	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—CRP—Kawasaki disease	0.00173	0.00195	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CCR5—Kawasaki disease	0.00172	0.00194	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—VEGFA—Kawasaki disease	0.0017	0.00192	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—VEGFA—Kawasaki disease	0.00168	0.0019	CbGpPWpGaD
Pranlukast—IL5—Immune System—CD4—Kawasaki disease	0.00167	0.00188	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CD40—Kawasaki disease	0.00156	0.00176	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ITPKC—Kawasaki disease	0.00141	0.00159	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CCR5—Kawasaki disease	0.00124	0.00139	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—CD4—Kawasaki disease	0.00117	0.00131	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—MMP9—Kawasaki disease	0.00115	0.0013	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—CD4—Kawasaki disease	0.00112	0.00126	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—VEGFA—Kawasaki disease	0.00103	0.00116	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CRP—Kawasaki disease	0.00101	0.00113	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—MMP9—Kawasaki disease	0.000941	0.00106	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ITPKC—Kawasaki disease	0.000928	0.00105	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—MMP9—Kawasaki disease	0.000876	0.000987	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—VEGFA—Kawasaki disease	0.000845	0.000952	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—VEGFA—Kawasaki disease	0.000787	0.000887	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CCR5—Kawasaki disease	0.000699	0.000788	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CD4—Kawasaki disease	0.000679	0.000766	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—MMP9—Kawasaki disease	0.000675	0.000761	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—VEGFA—Kawasaki disease	0.000607	0.000684	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MMP9—Kawasaki disease	0.000382	0.000431	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—VEGFA—Kawasaki disease	0.000343	0.000387	CbGpPWpGaD
